摘要
目的:分析胺碘酮联合倍他乐克急诊治疗室性心律失常临床疗效及心功能分析。方法:选取本院收治80例室性心律失常患者,随机将患者分为两组,对照组40例使用倍他乐克治疗,研究组40例在对照组基础上添加胺碘酮治疗,对两组患者临床疗效、心功能情况及不良反应发生情况进行比较。结果:研究组患者治疗总有效率为97.50%,明显高于对照组77.50%(P<0.05);研究组患者治疗后LVEF、ILVEDV及LVESV指标分别为(48.73±7.97)%、(132.32±10.38)ml、(76.20±13.08)inl,各项指标明显优于对照组(P<O.05);研究组患者不良反应发生率为5.00%,明显低于对照组20.00%(P<0.05)。结论:使用胺碘酮联合倍他乐克治疗室性心律失常患者,可改善患者心功能,减少其不良反应发生,有效提高治疗效果,值得临床推广使用。
Objective:To analyze the clinical efficacy and cardiac functions of amiodarone combined with betaloe in emergency treatment of ventricular arrhythmia.Methods:80 patients with ventricular arrhythmia receiving treatment in our hospital were randomized into two groups.40 patients in the control group were treated with betaloe,while another 40 patients in the study group were treated with amiodarone based on the control group.The clinical efficacy,cardiac functions and adverse reactions of the two groups were compared.Results:The total effective rate of the study group was 97.50%,which was significantly higher than that of the control group(77.50%)(P<0.05).The LVEF,ILVEDV and LVESV indexes of the study group after treatment were(48.73±7.97)%,(132.32±10.38)ml,and(76.20±13.08)ml,respectively,and the indexes were significantly better than those of the control group(P<0.05).The incidence of adverse reactions in patients of the study group was 5.00%,which was significantly lower than 20.00%in the control group(P<0.05).Conclusion:The use of amiodarone combined with betaloe in the treatment of patients with ventricular arrhythmia can improve the heart functions,reduce the occurrence of adverse reactions,and effectively improve the treatment effects,which was worthy of clinical promotion.
作者
霍健杨
HUO Jianyang(The First People's Hospital of Foshan,Foshan 528000,China)
出处
《华夏医学》
CAS
2019年第4期9-11,共3页
Acta Medicinae Sinica
关键词
胺碘酮
倍他乐克
室性心律失常
心功能
amiodarone
betaloe
ventricular arrhythmia
cardiac function
